Universal Vision Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Universal Vision Biotechnology has a total shareholder equity of NT$3.3B and total debt of NT$10.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are NT$5.1B and NT$1.8B respectively. Universal Vision Biotechnology's EBIT is NT$1.3B making its interest coverage ratio -393.6. It has cash and short-term investments of NT$1.6B.
Key information
0.3%
Debt to equity ratio
NT$9.97m
Debt
Interest coverage ratio | -393.6x |
Cash | NT$1.64b |
Equity | NT$3.34b |
Total liabilities | NT$1.79b |
Total assets | NT$5.13b |
Recent financial health updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06Financial Position Analysis
Short Term Liabilities: 3218's short term assets (NT$2.6B) exceed its short term liabilities (NT$1.0B).
Long Term Liabilities: 3218's short term assets (NT$2.6B) exceed its long term liabilities (NT$764.5M).
Debt to Equity History and Analysis
Debt Level: 3218 has more cash than its total debt.
Reducing Debt: 3218's debt to equity ratio has reduced from 9.5% to 0.3% over the past 5 years.
Debt Coverage: 3218's debt is well covered by operating cash flow (15581.1%).
Interest Coverage: 3218 earns more interest than it pays, so coverage of interest payments is not a concern.